> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# MIDD Paired Meeting Updates
- URL: https://www.fdaweb.com/midd-paired-meeting-updates/
- Published: 2022-11-03T12:00:00.000Z
- Updated: 2026-09-14T18:05:06.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5153121

FDA says PDUFA 7 includes an agency commitment to advancing modern approaches to enhance the efficiency of the drug development and review process, such as model-informed drug development (MIDD). The agency [says](https://www.fda.gov/drugs/development-resources/model-informed-drug-development-paired-meeting-program?utm%5Fmedium=email&utm%5Fsource=govdelivery) it intends to build on the MIDD paired meeting pilot by continuing to advance and integrate the development and application of exposure-based, biological, and statistical models derived from preclinical and clinical data sources in drug development and regulatory review.

PDUFA 7 updates to the MIDD Paired Meeting Program include the total number of granted submissions per quarter, meeting request submission due date, the timeline for meeting background package submission, and timing and scheduling of the follow-up meeting.